OR5B2
gene geneOn this page
Also known as OST073
Summary
OR5B2 (olfactory receptor family 5 subfamily B member 2, HGNC:8323) is a protein-coding gene on chromosome 11q12.1, encoding Olfactory receptor 5B2 (Q96R09). Odorant receptor.
Olfactory receptors interact with odorant molecules in the nose, to initiate a neuronal response that triggers the perception of a smell. The olfactory receptor proteins are members of a large family of G-protein-coupled receptors (GPCR) arising from single coding-exon genes. Olfactory receptors share a 7-transmembrane domain structure with many neurotransmitter and hormone receptors and are responsible for the recognition and G protein-mediated transduction of odorant signals. The olfactory receptor gene family is the largest in the genome.
Source: NCBI Gene 390190 — RefSeq curated summary.
At a glance
- GWAS associations: 4
- Clinical variants (ClinVar): 48 total
- MANE Select transcript:
NM_001005566
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:8323 |
| Approved symbol | OR5B2 |
| Name | olfactory receptor family 5 subfamily B member 2 |
| Location | 11q12.1 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | OST073 |
| Ensembl gene | ENSG00000172365 |
| Ensembl biotype | protein_coding |
| Entrez | 390190 |
Gene structure
Transcript identifiers
Ensembl transcripts: 2 — 2 protein_coding
ENST00000302581, ENST00000641342
RefSeq mRNA: 1 — MANE Select: NM_001005566
NM_001005566
CCDS: CCDS31550
Canonical transcript exons
ENST00000641342 — 3 exons
| Exon | Start | End |
|---|---|---|
| ENSE00003811658 | 58421238 | 58423289 |
| ENSE00003812672 | 58428019 | 58428121 |
| ENSE00003813496 | 58426622 | 58426676 |
Expression profiles
Bgee: expression breadth tissue_specific, 4 present calls, max score 41.18.
Top tissues by expression
107 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| lower esophagus mucosa | UBERON:0035834 | 41.18 | silver quality |
| adrenal tissue | UBERON:0018303 | 38.26 | gold quality |
| granulocyte | CL:0000094 | 37.29 | gold quality |
| calcaneal tendon | UBERON:0003701 | 37.25 | gold quality |
| colonic epithelium | UBERON:0000397 | 37.20 | gold quality |
| ventricular zone | UBERON:0003053 | 36.48 | gold quality |
| endometrium | UBERON:0001295 | 36.47 | gold quality |
| bone marrow cell | CL:0002092 | 36.16 | gold quality |
| mucosa of transverse colon | UBERON:0004991 | 36.15 | gold quality |
| superior frontal gyrus | UBERON:0002661 | 35.89 | gold quality |
| right coronary artery | UBERON:0001625 | 35.61 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 35.55 | gold quality |
| descending thoracic aorta | UBERON:0002345 | 35.50 | silver quality |
| ganglionic eminence | UBERON:0004023 | 35.49 | gold quality |
| apex of heart | UBERON:0002098 | 35.15 | gold quality |
| sural nerve | UBERON:0015488 | 35.04 | gold quality |
| skeletal muscle tissue | UBERON:0001134 | 34.97 | gold quality |
| blood | UBERON:0000178 | 34.50 | gold quality |
| liver | UBERON:0002107 | 34.28 | gold quality |
| bone marrow | UBERON:0002371 | 34.03 | gold quality |
| right uterine tube | UBERON:0001302 | 34.01 | gold quality |
| leukocyte | CL:0000738 | 33.95 | gold quality |
| monocyte | CL:0000576 | 33.94 | gold quality |
| corpus callosum | UBERON:0002336 | 33.67 | gold quality |
| muscle tissue | UBERON:0002385 | 33.36 | gold quality |
| tibial artery | UBERON:0007610 | 32.93 | gold quality |
| popliteal artery | UBERON:0002250 | 32.88 | gold quality |
| spleen | UBERON:0002106 | 32.58 | gold quality |
| lymph node | UBERON:0000029 | 32.57 | gold quality |
| cerebellar hemisphere | UBERON:0002245 | 32.29 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 3.62 |
Regulation
Is transcription factor: no
Cross-species orthologs
2 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Or5b99 | ENSMUSG00000046913 |
| rattus_norvegicus | Or5b99 | ENSRNOG00000087903 |
Paralogs (96): OR5C1 (ENSG00000148215), OR5F1 (ENSG00000149133), OR8K1 (ENSG00000150261), OR5M9 (ENSG00000150269), OR14K1 (ENSG00000153230), OR8J3 (ENSG00000167822), OR5I1 (ENSG00000167825), OR5AU1 (ENSG00000169327), OR9K2 (ENSG00000170605), OR8B12 (ENSG00000170953), OR10H3 (ENSG00000171936), OR8I2 (ENSG00000172154), OR8U1 (ENSG00000172199), OR10V1 (ENSG00000172289), OR5A1 (ENSG00000172320), OR5A2 (ENSG00000172324), OR5B12 (ENSG00000172362), OR9I1 (ENSG00000172377), OR9G4 (ENSG00000172457), OR5AR1 (ENSG00000172459), OR5AP2 (ENSG00000172464), OR8J1 (ENSG00000172487), OR5B3 (ENSG00000172769), OR10W1 (ENSG00000172772), OR5M3 (ENSG00000174937), OR5J2 (ENSG00000174957), OR10H4 (ENSG00000176231), OR5AN1 (ENSG00000176495), OR14C36 (ENSG00000177174), OR6B3 (ENSG00000178586), OR10Q1 (ENSG00000180475), OR8G2P (ENSG00000181214), OR5AK2 (ENSG00000181273), OR5AK3P (ENSG00000181282), OR5M8 (ENSG00000181371), OR8D4 (ENSG00000181518), OR8H1 (ENSG00000181693), OR8K5 (ENSG00000181752), OR8H3 (ENSG00000181761), OR8H2 (ENSG00000181767)
Protein
Protein identifiers
Olfactory receptor 5B2 — Q96R09 (reviewed: Q96R09)
Alternative names: OST073, Olfactory receptor OR11-240
All UniProt accessions (1): Q96R09
UniProt curated annotations — full annotation on UniProt →
Function. Odorant receptor.
Subcellular location. Cell membrane.
Similarity. Belongs to the G-protein coupled receptor 1 family.
RefSeq proteins (1): NP_001005566* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR000276 | GPCR_Rhodpsn | Family |
| IPR000725 | Olfact_rcpt | Family |
| IPR017452 | GPCR_Rhodpsn_7TM | Domain |
Pfam: PF13853
UniProt features (20 total): topological domain 8, transmembrane region 7, sequence variant 2, chain 1, glycosylation site 1, disulfide bond 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q96R09-F1 | 90.06 | 0.70 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Disulfide bonds (1): 95–187
Glycosylation sites (1): 3
Function
Pathways and Gene Ontology
Reactome pathways
1 pathways
| ID | Pathway |
|---|---|
| R-HSA-9752946 | Expression and translocation of olfactory receptors |
MSigDB gene sets: 17 (showing top):
GOBP_SENSORY_PERCEPTION_OF_CHEMICAL_STIMULUS, GOBP_DETECTION_OF_STIMULUS, GOBP_SENSORY_PERCEPTION, GOMF_OLFACTORY_RECEPTOR_ACTIVITY, GOMF_TRANSMEMBRANE_SIGNALING_RECEPTOR_ACTIVITY, GOMF_ODORANT_BINDING, GOMF_G_PROTEIN_COUPLED_RECEPTOR_ACTIVITY, GOBP_SENSORY_PERCEPTION_OF_SMELL, GOBP_G_PROTEIN_COUPLED_RECEPTOR_SIGNALING_PATHWAY, GOBP_DETECTION_OF_STIMULUS_INVOLVED_IN_SENSORY_PERCEPTION, REACTOME_OLFACTORY_SIGNALING_PATHWAY, REACTOME_SENSORY_PERCEPTION, GOBP_DETECTION_OF_CHEMICAL_STIMULUS, GOMF_MOLECULAR_TRANSDUCER_ACTIVITY, chr11q12
GO Biological Process (4): G protein-coupled receptor signaling pathway (GO:0007186), sensory perception of smell (GO:0007608), signal transduction (GO:0007165), detection of chemical stimulus involved in sensory perception of smell (GO:0050911)
GO Molecular Function (3): G protein-coupled receptor activity (GO:0004930), olfactory receptor activity (GO:0004984), odorant binding (GO:0005549)
GO Cellular Component (2): plasma membrane (GO:0005886), membrane (GO:0016020)
Reactome top-level categories
Rollup of top-1 pathways:
| Category | Pathways |
|---|---|
| Olfactory Signaling Pathway | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| transmembrane signaling receptor activity | 2 |
| G protein-coupled receptor activity | 1 |
| signal transduction | 1 |
| sensory perception of chemical stimulus | 1 |
| cell communication | 1 |
| cellular process | 1 |
| signaling | 1 |
| regulation of cellular process | 1 |
| cellular response to stimulus | 1 |
| sensory perception of smell | 1 |
| detection of chemical stimulus involved in sensory perception | 1 |
| G protein-coupled receptor signaling pathway | 1 |
| detection of chemical stimulus involved in sensory perception of smell | 1 |
| binding | 1 |
| membrane | 1 |
| cell periphery | 1 |
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
56 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| OR5B2 | NPEPL1 | Q8NDH3 | 582 |
| OR5B2 | XYLB | O75191 | 475 |
| OR5B2 | LAMA1 | P25391 | 311 |
| OR5B2 | PHYHIP | Q92561 | 307 |
| OR5B2 | TOMM40 | O96008 | 292 |
| OR5B2 | THOC7 | Q6I9Y2 | 272 |
| OR5B2 | APOC1 | P02654 | 272 |
| OR5B2 | CYP24A1 | Q07973 | 270 |
| OR5B2 | MED8 | Q96G25 | 247 |
| OR5B2 | PLAUR | Q03405 | 166 |
| OR5B2 | TNP2 | Q05952 | 162 |
| OR5B2 | GNAL | P38405 | 109 |
| OR5B2 | GNAS | Q5JWF2 | 109 |
| OR5B2 | OSCAR | Q8IYS5 | 102 |
| OR5B2 | GNG8 | Q9UK08 | 80 |
IntAct
0 interactions, top by confidence:
BioGRID (1): OR5B2 (Affinity Capture-MS)
ESM2 similar proteins: A6NL26, O14581, O76100, O95006, P34986, P37068, P37070, P37071, P58173, Q5TZ20, Q60890, Q60893, Q6IEU7, Q8N146, Q8NGA1, Q8NGE9, Q8NGG1, Q8NGG4, Q8NGI9, Q8NGL2, Q8NGP8, Q8NGQ1, Q8NGQ6, Q8NGS0, Q8NGZ4, Q8NGZ9, Q8NH01, Q8NH04, Q8NHC8, Q8VEW5, Q8VEZ0, Q8VF65, Q8VF66, Q8VF76, Q8VFD2, Q8VFL9, Q8VFM9, Q8VFX2, Q8VG02, Q8VG05
Diamond homologs: A0A3B3IT45, A4D2G3, A6NF89, A6NGY5, A6NL08, A6NL26, A6NMU1, A6NND4, O88628, P0C629, P0C646, P0C7N1, P0C7T3, P23266, P23273, P23274, P30954, Q13606, Q60888, Q62007, Q6IF63, Q6IFG1, Q6W049, Q8NGA6, Q8NGF0, Q8NGF1, Q8NGF3, Q8NGG8, Q8NGH5, Q8NGH6, Q8NGH7, Q8NGH8, Q8NGH9, Q8NGI0, Q8NGI1, Q8NGI2, Q8NGI3, Q8NGI7, Q8NGJ2, Q8NGJ3
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
48 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 45 |
| Likely benign | 3 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
171 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 11:58422850:CA:C | donor_gain | 0.9900 |
| 11:58423245:T:TA | donor_gain | 0.9600 |
| 11:58422849:A:AC | donor_gain | 0.9000 |
| 11:58422850:C:CC | donor_gain | 0.9000 |
| 11:58422823:ATGAG:A | donor_gain | 0.8700 |
| 11:58422993:A:AC | donor_gain | 0.8400 |
| 11:58422842:G:C | donor_gain | 0.8300 |
| 11:58422995:G:T | donor_gain | 0.8300 |
| 11:58423025:G:T | donor_gain | 0.8300 |
| 11:58422631:C:CC | acceptor_gain | 0.8200 |
| 11:58422892:CTG:C | donor_gain | 0.8100 |
| 11:58423024:TG:T | donor_gain | 0.8100 |
| 11:58423092:A:C | donor_gain | 0.8000 |
| 11:58423070:CAGG:C | donor_gain | 0.7800 |
| 11:58423023:A:AC | donor_gain | 0.7700 |
| 11:58423087:A:AC | donor_gain | 0.7500 |
| 11:58422628:TAA:T | acceptor_gain | 0.7300 |
| 11:58422891:A:AC | donor_gain | 0.7300 |
| 11:58422892:C:CC | donor_gain | 0.7300 |
| 11:58422855:G:A | donor_gain | 0.7000 |
| 11:58422937:C:CT | donor_gain | 0.6900 |
| 11:58423076:A:AC | donor_gain | 0.6900 |
| 11:58423077:C:CC | donor_gain | 0.6900 |
| 11:58423246:C:A | donor_gain | 0.6900 |
| 11:58422626:GATAA:G | acceptor_gain | 0.6700 |
| 11:58423060:C:CT | donor_gain | 0.6500 |
| 11:58422840:CAG:C | donor_gain | 0.6300 |
| 11:58422938:C:CT | donor_gain | 0.6200 |
| 11:58423218:AGT:A | donor_gain | 0.6200 |
| 11:58422994:TG:T | donor_gain | 0.6000 |
AlphaMissense
2050 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 11:58423232:G:C | F10L | 0.923 |
| 11:58423232:G:T | F10L | 0.923 |
| 11:58423234:A:G | F10L | 0.923 |
| 11:58422737:A:C | F175L | 0.869 |
| 11:58422737:A:T | F175L | 0.869 |
| 11:58422739:A:G | F175L | 0.869 |
| 11:58422734:G:C | F176L | 0.824 |
| 11:58422734:G:T | F176L | 0.824 |
| 11:58422736:A:G | F176L | 0.824 |
| 11:58422764:G:C | F166L | 0.821 |
| 11:58422764:G:T | F166L | 0.821 |
| 11:58422766:A:G | F166L | 0.821 |
| 11:58423233:A:G | F10S | 0.798 |
| 11:58422776:G:C | F162L | 0.764 |
| 11:58422776:G:T | F162L | 0.764 |
| 11:58422778:A:G | F162L | 0.764 |
| 11:58422515:G:C | F249L | 0.751 |
| 11:58422515:G:T | F249L | 0.751 |
| 11:58422517:A:G | F249L | 0.751 |
| 11:58422437:G:C | F275L | 0.731 |
| 11:58422437:G:T | F275L | 0.731 |
| 11:58422439:A:G | F275L | 0.731 |
| 11:58422968:C:A | Q98H | 0.729 |
| 11:58422968:C:G | Q98H | 0.729 |
| 11:58422962:G:C | F100L | 0.724 |
| 11:58422962:G:T | F100L | 0.724 |
| 11:58422964:A:G | F100L | 0.724 |
| 11:58422956:A:C | F102L | 0.719 |
| 11:58422956:A:T | F102L | 0.719 |
| 11:58422958:A:G | F102L | 0.719 |
dbSNP variants (sampled 300 via entrez): RS1000103913 (11:58428917 C>A), RS1000137295 (11:58423501 G>A), RS1000199245 (11:58426768 T>C), RS1000547240 (11:58429402 A>G), RS1000578893 (11:58428581 A>G), RS1001168008 (11:58422191 A>G), RS1001383577 (11:58428041 A>G), RS1001617765 (11:58422782 G>A), RS1001770955 (11:58429185 C>A,T), RS1001800431 (11:58429355 G>A), RS1002843008 (11:58420766 T>C), RS1003173166 (11:58421016 A>C,G), RS1003440779 (11:58427799 T>A,C), RS1003473982 (11:58428099 G>T), RS1003747635 (11:58425645 A>G)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
4 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST004133_47 | Ulcerative colitis | 9.000000e-06 |
| GCST006919_4 | Ability to confide in someone | 9.000000e-08 |
| GCST006923_2 | Loneliness | 3.000000e-06 |
| GCST006924_11 | Loneliness (MTAG) | 8.000000e-09 |
EFO canonical traits (2, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0009592 | social interaction measurement |
| EFO:0007865 | loneliness measurement |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
4 total (human), top 4 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| CGP 52608 | affects binding, increases reaction | 1 |
| theaflavin-3,3’-digallate | affects expression | 1 |
| Benzo(a)pyrene | increases methylation | 1 |
| Valproic Acid | decreases methylation | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.